Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors

NCT04435756 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT04435756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Active, not recruiting
Start date
July 28, 2020
Completion date
January 1, 2028
Enrollment
956 (estimated)
Sites
424

Conditions

As the registry lists them; a condition with its own page is linked.

germ cell tumor, metachronous malignant neoplasm, seminoma, stage i testicular cancer ajcc v8, stage ia testicular cancer ajcc v8, stage ib testicular cancer ajcc v8, stage is testicular cancer ajcc v8